Family history of colorectal cancer in Iran
2005; 5: 112
Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics
2005; 5: 98
Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes
2005; 5: 99
Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer?
2005; 5: 111
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours
2005; 5: 113
Anthracyclines, proteasome activity and multi-drug-resistance
2005; 5: 114
Oral ulcer as an exclusive sign of gastric cancer: report of a rare case
2005; 5: 117
Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts
2005; 5: 121
Differential expression of MUC genes in endometrial and cervical tissues and tumors
2005; 5: 124
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer
2005; 5: 118
Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice
2005; 5: 115
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
2005; 5: 120
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample
2005; 5: 122
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma
2005; 5: 123
Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer
2005; 5: 125
Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis
2005; 5: 128
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer
2005; 5: 116
Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma
2005; 5: 119
Numbers of mutations to different types of colorectal cancer
2005; 5: 126
Survivin expression and its clinical significance in pancreatic cancer
2005; 5: 127
Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]
2005; 5: 131
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy
2005; 5: 132
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients
2005; 5: 133
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
2005; 5: 134
Differential biologic effects of CPD and 6-4PP UV-induced DNA damage on the induction of apoptosis and cell-cycle arrest
2005; 5: 135
Modeling the effect of age in T1-2 breast cancer using the SEER database
2005; 5: 130
Long-term all-sites cancer mortality time trends in Ohio, USA, 1970–2001: differences by race, gender and age
2005; 5: 136
Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report
2005; 5: 129
Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells
2005; 5: 140
Short- and long-term cause-specific survival of patients with inflammatory breast cancer
2005; 5: 137
Chance mechanisms affecting the burden of metastases
2005; 5: 138
The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
2005; 5: 139
Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines
2005; 5: 145
Association of paternal age at birth and the risk of breast cancer in offspring: a case control study
2005; 5: 143
Increased risk of cancer among relatives of patients with lung cancer in China
2005; 5: 146
Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases
2005; 5: 149
CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma
2005; 5: 141
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives
2005; 5: 147
Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma
2005; 5: 142
The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases
2005; 5: 144
Unusual explosive growth of a squamous cell carcinoma of the scalp after electrical burn injury and subsequent coverage by sequential free flap vascular connection – a case report
2005; 5: 150
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
2005; 5: 151
Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: Study in paraffin tissue sections
2005; 5: 148
The impact of age on post-operative outcomes of colorectal cancer patients undergoing surgical treatment
2005; 5: 153
Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn's disease patient
2005; 5: 157
Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer
2005; 5: 154
Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
2005; 5: 152
Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies
2005; 5: 155
Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo
2005; 5: 158
Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
2005; 5: 156
Correction: Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer
2005; 5: 164
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death
2005; 5: 161
Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation
2006; 6: 1
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer
2005; 5: 159
Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study
2005; 5: 160
Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
2005; 5: 162
Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe
2006; 6: 6
The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma
2006; 6: 8
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
2006; 6: 3
Kinetics of cancer: a method to test hypotheses of genetic causation
2005; 5: 163
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
2006; 6: 15
Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells
2006; 6: 12
The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
2006; 6: 9
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
2006; 6: 5
Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea
2006; 6: 2
Hidden chromosomal abnormalities in pleuropulmonary blastomas identified by multiplex FISH
2006; 6: 4
A phase 1–2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]
2006; 6: 29
BACH1 Ser919Pro variant and breast cancer risk
2006; 6: 19
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
2006; 6: 27
Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
2006; 6: 31
Spontaneous regression of bone metastasis from renal cell carcinoma; A case report
2006; 6: 11
Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines
2006; 6: 13
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway
2006; 6: 14
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006; 6: 28
Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231]
2006; 6: 35
Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity
2006; 6: 10
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
2006; 6: 34
Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
2006; 6: 16
Sperm protein 17 is expressed in human nervous system tumours
2006; 6: 23
Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL and EVPL in esophageal squamous cell carcinoma
2006; 6: 33
The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report
2006; 6: 7
Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited
2006; 6: 20
A novel approach for rapid screening of mitochondrial D310 polymorphism
2006; 6: 21
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts
2006; 6: 18
The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women
2006; 6: 24
Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma
2006; 6: 38
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line
2006; 6: 22
Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer
2006; 6: 42
A transcriptome anatomy of human colorectal cancers
2006; 6: 40
HFE H63D mutation frequency shows an increase in Turkish women with breast cancer
2006; 6: 37
Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein
2006; 6: 41
Hypoxia-inducible transcription factor-1α promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway
2006; 6: 26
A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas
2006; 6: 30
Inhibitors of apoptosis proteins in human cervical cancer
2006; 6: 45
Nestin expression in the cell lines derived from glioblastoma multiforme
2006; 6: 32
The knowledge and attitudes of breast self-examination and mammography in a group of women in a rural area in western Turkey
2006; 6: 43
Smad4-expression is decreased in breast cancer tissues: a retrospective study
2006; 6: 25
Prognosis of screen-detected breast cancers: results of a population based study
2006; 6: 17
Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer
2006; 6: 50
Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report
2006; 6: 47